Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trialChan Joon Kim, Jong‐Seon Park, Mahn‐Won Park et al.|The Lancet|2021Cited by 202
Impact of Intravascular Ultrasound on Long-Term Clinical Outcomes in Patients With Acute Myocardial InfarctionIk Jun Choi, Kiyuk Chang, Sungmin Lim et al.|JACC: Cardiovascular Interventions|2021Cited by 69
Impact of the Stent Length on Long-Term Clinical Outcomes Following Newer-Generation Drug-Eluting Stent ImplantationIk Jun Choi, Ki‐Bae Seung, Chul Soo Park et al.|The American Journal of Cardiology|2013Cited by 50
Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non–Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry)Ik Jun Choi, Pum-Joon Kim, Yoon‐Seok Koh et al.|The American Journal of Cardiology|2016Cited by 28
A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trialMahn‐Won Park, Kiyuk Chang, Chan Joon Kim et al.|EuroIntervention|2021Cited by 27